Left out but not forgotten: Should closer attention be paid to coinfection with herpes simplex virus type 1 and HIV?
- PMID: 20190881
- PMCID: PMC2690523
- DOI: 10.1155/2009/965263
Left out but not forgotten: Should closer attention be paid to coinfection with herpes simplex virus type 1 and HIV?
Abstract
Herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) are among the most common coinfections seen in individuals infected with HIV-1. Most research on HSV-HIV coinfection has focused on HSV-2, and in particular, on its impact on HIV transmission. HSV-2 is associated with micro- and macroulcerations in genital mucosal surfaces, increased numbers of HIV target cells in genital mucosal tissue and increases in plasma HIV viral load of up to 0.5 log(10) copies/mL, such that HSV-2 infection increases the risk of both HIV acquisition and transmission. Because plasma HIV RNA levels are a major determinant of rates of CD4 cell decline, HSV-2 coinfection may also adversely affect the progression of HIV disease. Anti-HSV medications have in fact been associated with reciprocal decreases in HIV viral load in short-term studies. These findings have led to the development of several clinical trials of HSV-2 suppression as strategies for preventing HIV transmission and slowing the rate of HIV disease progression. HSV-1 coinfection has largely been ignored from this growing body of research, yet there are several reasons that this coinfection remains an important issue for study. First, the seroprevalence of HSV-1 is consistently higher than that of HSV-2 among both HIV-infected and HIV-uninfected populations, underscoring the relevance of HSV-1 coinfection to the majority of HIV-infected persons. Second, pre-existing HSV-1 antibodies in individuals may modulate the course of subsequently acquired HSV-2 infection; the implications of such changes on HSV-HIV coinfection remain unexplored. Third, HSV-1 and HSV-2 are closely related viruses that share 83% genetic homology. Their virological and pathobiological similarities suggest that their implications on HIV pathogenesis may be similar as well. Finally, HSV-1 is becoming increasingly relevant because the incidence of genital HSV-1 has risen. Although genital herpes is traditionally associated with HSV-2, recent studies have shown that the majority of serologically confirmed primary genital herpes in some settings is attributable to HSV-1. Because the genital tract is an important site of biological interaction between HSV and HIV, this epidemiological change may be clinically important.
Les virus de l’herpès simplex de type 1 (VHS-1) et de type 2 (VHS-2) causent certaines des co-infections les plus souvent observées chez les sujets VIH-1 positifs. La majeure partie des recherches qui ont porté sur la co-infection VHS-VIH se sont attardées au VHS-2 et plus particulièrement à son impact sur la transmission du VIH. Le VHS-2 est associé à des micro- et des macro-ulcérations de la muqueuse génitale, à un nombre accru de cellules cibles du VIH dans les tissus de la muqueuse génitale et à des augmentations de la charge virale plasmatique du VIH jusqu’à 0,5 log10 copie/mL, de sorte que l’infection au VHS-2 accroît le risque de contracter et de transmettre le VIH. Étant donné que le taux d’ARN du VIH est un important facteur déterminant du déclin des lymphocytes CD4, la co-infection par le VHS-2 peut aussi accélérer la progression de la maladie au VIH. Les médicaments anti-VHS ont en fait été associés à des baisses réciproques de la charge virale du VIH lors d’études à court terme. Ces résultats ont conduit à la mise au point de plusieurs études cliniques sur la suppression du VHS-2 comme stratégie pour prévenir la transmission du VIH et ralentir la progression de la maladie qu’il cause. La co-infection par le VHS-1 a pour une bonne part été ignorée de ce corpus de recherche croissant et pourtant, à plusieurs points de vue, cette co-infection demeure une importante question à explorer. Tout d’abord, la séroprévalence du VHS-1 est toujours plus élevée que celle du VHS-2, tant chez les populations infectées par le VIH que chez les populations indemnes, ce qui rappelle la portée de la co-infection par le VHS-1 chez la majorité des personnes infectées par le VIH. Ensuite, la préexistence d’anticorps anti-VHS-1 chez les sujets pourrait influer sur l’évolution de l’infection au VHS-2 acquise par la suite. Les implications de ces changements sur la co-infection VHS-VIH restent méconnues. Troisièmement, le VHS-1 et le VHS-2 sont des virus étroitement apparentés qui partagent 83 % d’homologie génétique. Leurs similitudes virologiques et pathobiologiques donnent à penser que leurs implications dans la pathogenèse du VIH pourraient également être similaires. En terminant, le VHS-1 est de plus en plus pertinent en raison de l’augmentation de l’incidence du VHS-1 génital. Bien que l’herpès génital ait traditionnellement été associé au VHS-2, de récentes études ont montré que dans certains milieux, la majorité des cas d’herpès génital primaire confirmés par des analyses sérologiques est causée par le VHS-1. Étant donné que les voies génitales sont un important siège d’interaction biologique entre le VHS et le VIH, cette variation épidémiologique pourrait revêtir une importance clinique certaine.
Keywords: Coinfection; Genital herpes; HIV; HSV; Orolabial herpes.
Similar articles
-
Subclinical Genital Herpes Shedding in HIV/Herpes Simplex Virus 2-Coinfected Women during Antiretroviral Therapy Is Associated with an Increase in HIV Tissue Reservoirs and Potentially Promotes HIV Evolution.J Virol. 2020 Dec 9;95(1):e01606-20. doi: 10.1128/JVI.01606-20. Print 2020 Dec 9. J Virol. 2020. PMID: 33028713 Free PMC article.
-
The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment.J Virol. 2015 Sep;89(18):9559-70. doi: 10.1128/JVI.01326-15. Epub 2015 Jul 8. J Virol. 2015. PMID: 26157126 Free PMC article.
-
Herpes simplex virus type 2 coinfection does not accelerate CD4 count decline in untreated HIV infection.Clin Infect Dis. 2013 Aug;57(3):448-57. doi: 10.1093/cid/cit208. Epub 2013 Apr 9. Clin Infect Dis. 2013. PMID: 23572481
-
Estimated economic burden of genital herpes and HIV attributable to herpes simplex virus type 2 infections in 90 low- and middle-income countries: A modeling study.PLoS Med. 2022 Dec 15;19(12):e1003938. doi: 10.1371/journal.pmed.1003938. eCollection 2022 Dec. PLoS Med. 2022. PMID: 36520853 Free PMC article.
-
Infectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventions.Curr HIV Res. 2012 Apr;10(3):228-37. doi: 10.2174/157016212800618156. Curr HIV Res. 2012. PMID: 22384842 Free PMC article. Review.
Cited by
-
HSV1-induced enhancement of productive HIV-1 replication is associated with interferon pathway downregulation in human macrophages.Mem Inst Oswaldo Cruz. 2024 Oct 28;119:e240102. doi: 10.1590/0074-02760240102. eCollection 2024. Mem Inst Oswaldo Cruz. 2024. PMID: 39476027 Free PMC article.
-
Antiretroviral therapy is not associated with reduced herpes simplex virus shedding in HIV coinfected adults: an observational cohort study.BMJ Open. 2014 Jan 24;4(1):e004210. doi: 10.1136/bmjopen-2013-004210. BMJ Open. 2014. PMID: 24464523 Free PMC article.
-
Diagnostic Challenges of Lyme Co-infections: Lessons From a Lyme and Herpes Simplex Virus-1 (HSV-1) Cocktail.Cureus. 2024 May 13;16(5):e60213. doi: 10.7759/cureus.60213. eCollection 2024 May. Cureus. 2024. PMID: 38868243 Free PMC article.
-
Evaluating HIV Prevention Programs: Herpes Simplex Virus Type 2 Antibodies as Biomarker for Sexual Risk Behavior in Young Adults in Resource-Poor Countries.PLoS One. 2015 May 26;10(5):e0128370. doi: 10.1371/journal.pone.0128370. eCollection 2015. PLoS One. 2015. PMID: 26010772 Free PMC article.
-
Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in females.Int J Womens Health. 2012;4:341-50. doi: 10.2147/IJWH.S27601. Epub 2012 Jul 19. Int J Womens Health. 2012. PMID: 22927765 Free PMC article.
References
-
- McFarland W, Gwanzura L, Bassett MT, et al. Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers. J Infect Dis. 1999;180:1459–65. - PubMed
-
- Lama JR, Lucchetti A, Suarez L, et al. Association of herpes simplex virus type 2 infection and syphilis with human immunodeficiency virus infection among men who have sex with men in Peru. J Infect Dis. 2006;194:1459–66. - PubMed
-
- Kapiga SH, Sam NE, Bang H, et al. The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania. J Infect Dis. 2007;195:1260–9. 5. - PubMed
-
- Suligoi B, Dorrucci M, Volpi A, et al. Prevalence and determinants of herpes simplex virus type 2 infection in a cohort of HIV-positive individuals in Italy. Sex Transm Dis. 2002;29:665–7. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials